View Cart (0 items)

J&J recalls Tylenol Cold Nighttime Gelcaps

August 17, 2011
/ Print / Reprints /
| Share More
/ Text Size+

NEW BRUNSWICK, N.J. — Johnson & Johnson has voluntarily recalled about 2.45 million packages of Tylenol Cold Multi-Symptom Nighttime Rapid Release Gelcaps after discovering a higher level than expected of the chemical chlorpheniramine ammonio acetate (CPAA), according to The Associated Press.

The company initiated the recall as a precaution and no safety concerns have been associated with CPAA.

No action is required by consumers or healthcare providers and consumers can continue to use the product, the company said in a statement.
You must login or register in order to post a comment.